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Abstract
Background: The Two-Week Rule (TWR) was introduced to ensure that all patients with a 
suspected colorectal cancer (CRC) saw a hospital specialist within 14 days of an urgent GP referral. 
Guidelines were available to GPs to facilitate the appropriate TWR referral of patients exhibiting 
high-risk CRC symptoms.
Methods: We aimed to evaluate the TWR and its CRC detection rate on NHS CRC diagnostic 
services by performing a literature search and critically appraising the peer-reviewed studies. Only 
12 studies were eligible for inclusion. Data was collected and overall results were given as weighted 
averages.
Results: The studies identified indicated that only 10.3% of patients referred by the TWR were 
eventually diagnosed with CRC. When examining the referral origin of all CRC patients diagnosed 
during the time of the studies, 24% had been referred using the TWR, 24.1% were referred as 
emergency cases, and 52.4% were referred using alternative routes. No evidence was found to 
indicate that the TWR had resulted in identifying CRC patients at an earlier, more treatable stage 
of their disease.
Conclusion: The TWR referral system needs to be improved to increase the number of CRC 
patients referred using this fast track method as they present to  their GP. The TWR and new NICE 
Guidelines for the referral of patients with suspected cancer should be independently evaluated.
Background
The Government set targets to be achieved by 2000 for 
NHS Trusts in England and Wales to see patients with sus­
pected cancer within two weeks of an urgent referral by 
their GP [1], where "suspected" was defined as either a 
perceived level of probability or a hunch [2]. This was 
achieved by the implementation of the Two-Week Rule 
(TWR) for fast tracking suspected cancer referrals from pri­
mary to secondary care [3].
To facilitate the appropriate use of the TWR, Guidelines 
were published by the Department of Health (DoH) 
detailing the high-risk criteria exhibited by patients with 
suspected cancer [4]. In the case of colorectal cancer 
(CRC), the Guidelines' list of high-risk symptoms aimed 
to "identify up to 90 per cent of patients with bowel can­
cer" to be urgently referred using the TWR. The Guidelines 
recommended that a patient needed to exhibit a combina­
tion of the high-risk symptoms to be appropriately 
referred using the TWR. Patients referred using the TWR
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Tab le  1: Descrip tion o f th e  studies used in this paper.
http://www.biomedcentral.com/1472-6963/6/43
F irs t a u th o r &  R eference Location o f study S tudy T y p e T im e  p e rio d  studied
Chohan [6] Addenbrookes Hospital, Cambridge
Maruthachalam [7] Newcastle upon Tyne NHS Trust
Eccersley [8] Luton & Dunstable NHS Trust
Walsh [9] Blackpool Victoria Hospital, Blackpool
Debnath [10] South Durham Healthcare Trust
Flashman [11] Queen Alexandra Hospital, Portsmouth
Barwick [12] St James' University Hospital, Leeds
Tricket [13] Ashford & St Peter's Hospital NHS Trust
Retrospective observational study 
Prospective evaluative study 
Prospective audit 
Prospective audit 
Prospective audit 
Prospective audit 
Retrospective observational study 
Prospective observational study t
Jul 2000 to  Dec 2001 
Jan to  Dec 2003 
Jan 2000 to  March 2001 
Aug to  O ct 2000 
Aug 2000 to  Jul 2001 
Jul 2000 to  Jun 2001 
Jan to  Aug 2001 
Nov 2000 to  O ct 2001
Key: t  Study looked at CRC patients only
that did no t exhibit at least two of the criteria would be 
considered inappropriate referrals.
Since 2000, English NHS Trusts have reported their com­
pliance with the TWR to the DoH on a quarterly basis. The 
report for the first Quarter of 2005/06 showed that 99.5% 
of all patients referred with a suspected lower gastrointes­
tinal cancer via the TWR were seen within two weeks [5].
A recent publication by Chohan et al highlighted the suc­
cess of the TWR in speeding up patients' access to clinics 
at their hospital bu t reported a low CRC detection rate of 
27%. The CRC patients diagnosed via this route also 
tended to have more advanced stage of the disease [6].
In light of this, we performed a literature search to evalu­
ate all peer-reviewed evidence reporting on the TWR and 
its CRC detection rate within NHS CRC diagnostic services 
to determine whether the TWR was effective in identifying 
suspected CRC patients, and whether they were diagnosed 
at an earlier stage of their disease.
Methods
A literature search was performed using Medline, the 
Cochrane Library, the National Library for Health (NLH), 
the Health Management Information Consortium 
(HMIC) and the Centre for Reviews and Dissemination 
(CRD), employing a text search for peer-reviewed research 
publications. The search terms used were "colorectal" or 
"CRC" in combination with "urgent referral*", "two 
week*", "2-week* " and "fourteen day*".
Studies performed outside England and Wales were 
excluded, as were studies performed prior to the imple­
mentation of the TWR in July 2000 or in non-NHS organ­
isations. Only peer-reviewed studies commenting on the 
effectiveness of the TWR in NHS CRC diagnostic services 
were selected based on the abstract by one author (KT).
Data describing the TWR CRC detection rate and the refer­
ral routes of CRC patients identified during the study were 
extracted, as well as any reports on the stage of the disease
in CRC patients. Data extracted were actual values. All 
studies with comparable datasets were combined to give 
overall results, given as weighted averages.
Results
During the initial search for literature, a total of 123 arti­
cles were retrieved. O f these, 103 were immediately 
excluded because they did not refer to TWR in any way. Of 
the remaining 20 articles, one did n o t relate directly to 
TWR efficiency, four studies were done prior to the official 
implementation on TWR in July 2000 and three were let­
ters. This left 12 articles suitable for inclusion. Of these, 
only eight had comparable data reporting on the effect of 
the TWR in NHS CRC diagnostic services. These studies 
consisted of two retrospective studies and six prospective 
studies, four of which were based on audits (see Table 1). 
These studies were performed between 2000 and 2003.
The studies identified showed that of the 2440 patients 
referred by their GP using the TWR, only 10.3 per cent 
were subsequently diagnosed with CRC (see Table 2).
When determining the referral route of all CRC patients 
diagnosed during the time of the studies identified, we 
found that only 24 per cent of CRC patients were referred 
by GPs using the TWR, [6-13] with a further 24.1 per cent 
being referred as emergency cases [6-8,11-13]. The 
remaining 52.4 per cent had been referred by other routes 
(see Table 2) [6-8,11-13]. For two studies, [9,10] the 
num ber of emergency cases could n o t be extracted from 
the non-TWR referrals and were no t included in the sum­
mary values above.
Although most patients were seen by a hospital specialist 
within the two-week target, no studies reported any signif­
icant difference in the stage of the disease of CRC patients 
referred and diagnosed using the TWR compared with 
other referral routes [6,8,11,14].
Of the four articles retrieved in the literature search but 
no t included in Table 1, one was a systematic review of 
cancer waiting time audits [15] commissioned by the
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Tab le  2: D a ta  fro m  eight peer-review ed studies describing th e  effect o f th e  T W R  on th e ir  co lorectal services.
F irs t au th o r  
&  R eference
N ° T W R
referra ls
received
(i)  % o f C RC s identified  
fro m  T W R  re ferra ls  (n )
T o ta l n u m b e r o f 
C R C
cases diagnosed f
T W R
T o ta l % o f C R C  cases 
re fe rre d  as...
E m ergency O th e r
Chohan [6] 462 13.8% (64) l95 32.8% 20% 47.2%
Maruthachalam [7] 639 8% (51) 234 21.8% 10.6% 67.6%
Eccersley [8] 180 14.4% (26) l45 18% 17% 66%
Walsh [9] 78 10.3% (8) 23 47.8% 52.2%
Debnath [10] 237 8.9% (2 l) 96 21.9% 78.1%
Flashman [11] 695 9.4% (65) 249 26.1% 35.3% 38.6%
Barwick [12] 149 10% (14) 84 16.7% 41.7% 41.7%
Tricket [13] NA NA l47 20% 29% 5l%
W e ig h te d  averages o f all 10.3% 24% 24.1% 52.4%
values com bined
Key: NA = Data not available in article; f  = Total number of CRC cases diagnosed during the time of the study in the same locality.
DoH to inform the new NICE Guidelines [16] and pub­
lished by the CRD. This review identified a total of 39 hos­
pital audits relating to lower GI cancer. From these, the 
review reported that the CRC detection rate for the TWR 
ranged from 2 -  22 per cent and that between 0 -  47 per 
cent of CRC patients were referred using the TWR.
The remaining three studies retrieved by the literature 
search included a qualitative assessment of the DoH 
Guidelines, [14] one focussed on the impact of a fast track 
barium enema service, [17] and one reported on varia­
tions in the evaluation of CRC risk [18].
Discussion
Although the DoH Guidelines aimed to identify 90 per 
cent of CRC patients as they presented to their GP, the lit­
erature identified by this paper indicated that only 10.3 
per cent were eventually diagnosed with CRC. This figure 
is based on the assumption that all TWR referrals were 
appropriate. Less than a quarter of all CRC patients had 
been referred using the TWR, the same proportion had 
been referred as emergency cases and just over half of all 
CRC patients diagnosed during the time of the studies had 
been referred using alternative routes. There was no evi­
dence to indicate any significant improvement in detect­
ing CRC at an earlier stage in CRC patients referred using 
the TWR compared to those referred by alternative routes.
This paper reviewed all relevant peer-reviewed evidence 
from studies performed after 2000 reporting on the 
impact of the TWR. There was a limited am ount of peer- 
reviewed literature in this field, with only 12 publications 
meeting our inclusion criteria, and only eight of these 
reporting comparable datasets. A single researcher 
assessed the literature, but the tight focus on the inclusion 
and exclusion criteria should have reduced any bias in the 
selection of eligible studies. As far as we are aware, no
other evaluation of the literature in this field has been per­
formed to date.
Our assessment of the guidelines was based on calculating 
the percentage of TWR-referred patients eventually diag­
nosed with CRC from all the studies and determining a 
weighted average. We also compared the proportion of 
CRC patients referred by the TWR compared with alterna­
tive routes into secondary care using weighted averages 
calculated from the original papers.
The low number of CRC patients identified following a 
TWR referral suggests that the Guidelines were not as 
effective in identifying CRC patients as they presented to 
their GP as was hoped. This may be explained by GPs 
referring patients who did no t conform to the Guidelines, 
possibly due to the incorrect interpretation of the Guide­
lines or to intentionally speed up diagnoses in low-risk 
patients where the routine waiting list was too long.
The studies identified reported that the proportion of CRC 
patients diagnosed by alternative routes (excluding emer­
gencies) was more than double those referred using the 
TWR. These patients may no t have exhibited any of the 
high-risk symptoms specified by the Guidelines, or they 
may have been internally referred following radiological 
or pathological investigations from within secondary care, 
where the TWR cannot be applied. Alternatively, it may be 
the result of the referral practices of GPs [19]. These high 
numbers of non-TWR referrals are cause for concern and 
the TWR referral methodology may need to be changed to 
capture these CRC patients.
Almost a quarter of all CRC patients were diagnosed fol­
lowing an emergency referral, although we were unable to 
determine whether the source of their referral was primary 
or secondary care. The majority of CRC patients diag­
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nosed following this route could not have been diverted 
onto the TWR route if they presented with "emergency" 
symptoms in need of immediate treatment, especially if 
they presented to A&E instead of their GP.
The TWR did not result in CRC patients being diagnosed 
at an earlier, more treatable stage of their disease. This 
could be because patients correctly referred using the TWR 
Guidelines need to exhibit high-risk symptoms indicative 
of later stage CRC, whilst early stage CRC patients may not 
have any alarm symptoms and may have been referred 
using alternative routes.
Although CRC lacks any highly specific symptoms [12], 
Selvachandran et al have successfully used a patient ques­
tionnaire to prioritise CRC referrals [20]. The studies iden­
tified in this review have shown that compiling highly 
specific Guidelines for symptomatic CRC patients using 
TWR referrals without compromising on their ability to 
detect early CRC can be problematic [8,10,13,14]. A liter­
ature search performed by Hamilton and Sharp concluded 
that the DoH Guidelines were based on a reasonable evi­
dence base [21] bu t the studies identified for this paper 
indicate otherwise, although it is worth noting that TWR 
referrals were assumed to be appropriate in accordance 
with the Guidelines. Research into the positive predictive 
value of CRC symptoms in the UK population is ongoing
[22] to improve the sensitivity and specificity of the 
Guidelines, although the revised TWR referral Guidelines 
by NICE [16], published in 2005, are almost identical to 
the original DoH Guidelines and so, are no t likely to 
increase the proportion of CRC patients diagnosed using 
the TWR.
The TWR was rapidly implemented throughout NHS can­
cer diagnostic services with no pilot studies done to indi­
cate potential problems. Both primary and secondary care 
services had to cope with the new referral protocols and 
their subsequent impact on services. We would question 
whether the TWR has had any positive effect on the iden­
tification of CRC patients at an earlier stage of their dis­
ease. To address this, we recommend that the TWR and 
the revised NICE Guidelines should be officially evaluated 
by an independent group to determine whether there is 
any subsequent increase in  the identification of CRC 
patients, accompanied by an improvement in the cancer 
stage at diagnosis to make the TWR worthwhile. A small 
scale evaluation has already been successfully established
[23] and could be used as a basis for a nationwide study. 
We also recommend that the new NICE Guidelines be 
made compulsory for all GPs and that TWR referral docu­
m entation is standardised so that comparisons can be 
made during any evaluations.
Conclusion
The evidence presented in this paper indicates that the 
detection rate for TWR-referred CRC was low and approx­
imately half of all CRC patients are referred by alternative 
routes prior to their diagnosis. Although m ost patients 
were seen by a hospital specialist within two weeks of 
referral, the TWR did not result in the identification of 
CRC patients at an earlier stage of their disease. We con­
clude that the TWR referral system is in need of improve­
m ent and independent evaluation.
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